CAS 1000676-41-4

Lirilumab

CAS : 1000676-41-4

Lirilumab (IPH2102) is an antibody against the lethal immunoglobulin-like receptor antibody KIR2D with antitumor activity that enhances the anti-HPV + cervical

Degré de pureté : 98.4% (SEC-HPLC) - >95.0% (SDS-PAGE)

Couleur et forme : Liquid

Masse moléculaire : 145.52 kDa (Predicted)

Ref: TM-T77423

Lirilumab

CAS : 1000676-41-4

Degré de pureté : 98%

Ref: IN-DA027G8I